Expanded Hemodialysis Therapy Market Growth, Size, Trends, Revenue, Share and Future Outlook
Expanded Hemodialysis Therapy Market Size- Product, By Modality, Application By End user- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Nov-2023 | Report ID: HLCA2365 | Pages: 1 - 235 | Formats*: |
| Category : Healthcare | |||
Expanded Hemodialysis Therapy Market Introduction and Overview
According to SPER Market Research, the Global Expanded Hemodialysis Therapy Market is estimated to reach USD XX billion by 2033 with a CAGR of 5.0%.
The report includes an in-depth analysis of the Global Expanded Hemodialysis Therapy market, including market size and trends, product mix, distribution channels, and supplier analysis. A life-sustaining treatment for patients with end-stage kidney disease is hemodialysis. It assists in the blood's removal of waste materials, extra fluid, and electrolytes, all of which help control and lessen kidney failure symptoms. Hemodialysis is not a cure for kidney disease, although it can greatly enhance many patients' quality of life. For a few, it acts as a stopgap measure before kidney transplantation, the permanent cure for kidney failure.
-00635592112023.jpg)
Market Opportunities and Challenges
Opportunities: The growing number of people worldwide who suffer from chronic renal illnesses. Due to the fact that kidney failure halts the process of cleansing blood and waste outflow, innovative medical devices must be used externally to filter the blood. Therefore, it is projected that throughout the forecast period, the growing prevalence of chronic renal disorders worldwide would present profitable potential prospects for market expansion. Furthermore, Diabetes and hypertension have increased significantly in recent years as a result of poor diet, sedentary lifestyle, limited physical exercise, increasing alcohol intake, and other factors. People who have such disorders are thought to be more likely to acquire a kidney ailment. Thus, renal failure due to lifestyle illnesses is expected to boost adoption of expanded hemodialysis therapy and, as a result, market size.
Challenges: The risks and complications that come with dialysis Patients receiving expanded hemodialysis treatments can have severe side effects while receiving treatment. Anemia, or the body's lack of red blood cells, is one of the most frequent side effects. Additionally, patients undergoing extended hemodialysis may have body-wide pain, warmth, redness, and swelling. Combined, these challenges will make it difficult for the industry to grow throughout the projected timeframe. The dialysis market is extremely competitive and diverse due to its large number of competitors. In the hemodialyser and peritoneal dialysis market, Tier I companies, mid-tier companies, and start-up companies all compete. Businesses are trying to get visibility in the market in this fiercely competitive field.
-00636042112023.jpg)
Market Competitive Landscape
The market for Expanded Hemodialysis Therapy is highly consolidated. Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc. Some of the market key players in global Expanded Hemodialysis Therapy market.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Product, By Modality, Application By End User |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc. |
COVID-19 Impact on Global Expanded Hemodialysis Therapy Market
The COVID-19 pandemic impacted nearly all industries and caused severe financial difficulty for healthcare services by rising healthcare costs. The adoption of social distancing norms and the change of standard operating procedures impeded the day-to-day functioning of numerous healthcare services, including dialysis processes. Many hospitals halted or rescheduled routine care and only offered emergency care. Despite the coronavirus epidemic, emergency dialysis procedures were performed in medical facilities. As the number of COVID-19 cases dropped in numerous countries, healthcare facilities resumed delivering healthcare services, eventually returning to pre-pandemic levels and positively improving the market landscape.
Key Target Audience
- Nephrologists and Healthcare Providers
- Dialysis Centers and Hospitals
- Patients with Kidney Disease
- Caregivers and Family Members
- Medical Device Manufacturers
- Pharmaceutical Companies
- Healthcare Insurers and Payers
- Regulatory Agencies
- Researchers and Academics
Our in-depth analysis of the Expanded Hemodialysis Therapy Market includes the following segments:
| By Product: |
|
| By Modality: |
|
| By Application: |
|
| By End Use: |
|
| By Region: |
|
Key Topics Covered in the Report
- Global Expanded Hemodialysis Therapy Market Size (FY’2023-FY’2033)
- Overview of Global Expanded Hemodialysis Therapy Market
- Segmentation of Global Expanded Hemodialysis Therapy Market By Product (Machine, Dialyzers, Concentrates, Dialysates, Catheters)
- Segmentation of Global Expanded Hemodialysis Therapy Market By Modality (Short Daily, Conventional Long Term, Nocturnal)
- Segmentation of Global Expanded Hemodialysis Therapy Market By Application (Priced Equipment, Service, Consumable, Drug)
- Segmentation of Global Expanded Hemodialysis Therapy Market By End User (Hospital, Independent Dialysis, Home Dialysis)
- Statistical Snap of Global Expanded Hemodialysis Therapy Market
- Expansion Analysis of Global Expanded Hemodialysis Therapy Market
- Problems and Obstacles in Global Expanded Hemodialysis Therapy Market
- Competitive Landscape in the Global Expanded Hemodialysis Therapy Market
- Impact of COVID-19 and Demonetization on Global Expanded Hemodialysis Therapy Market
- Details on Current Investment in Global Expanded Hemodialysis Therapy Market
- Competitive Analysis of Global Expanded Hemodialysis Therapy Market
- Prominent Players in the Global Expanded Hemodialysis Therapy Market
- SWOT Analysis of Global Expanded Hemodialysis Therapy Market
- Global Expanded Hemodialysis Therapy Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Expanded Hemodialysis Therapy Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Expanded Hemodialysis Therapy Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Expanded Hemodialysis Therapy Market
7. Global Expanded Hemodialysis Therapy Market, By Product (USD Million)
7.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By Product, 2023-20337.2. Machine7.3. Dialyzers7.4. Concentrates7.5. Dialysates7.6. Catheters
8. Global Expanded Hemodialysis Therapy Market , By Modality (USD Million)
8.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By Modality, 2023-20338.2. Short Daily8.3. Conventional Long term8.4. Nocturnal
9. Global Expanded Hemodialysis Therapy Market , By Application (USD Million)
9.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By Application, 2023-20339.2. Priced Equipment9.3. Service9.4. Consumable9.5. Drug
10. Global Expanded Hemodialysis Therapy Market , By End Use (USD Million)
10.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By End Use, 2023-203310.2. Hospital10.3. Independent Dialysis10.4. Home Dialysis
11. Global Expanded Hemodialysis Therapy Market Forecast, 2019-2033 (USD Million)
11.1. Global Expanded Hemodialysis Therapy Market Size and Market Share
12. Global Expanded Hemodialysis Therapy Market, By Product, 2019-2033 (USD Million)
12.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Product (2019-2026)12.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Product (2027-2033)
13. Global Expanded Hemodialysis Therapy Market, By Modality, 2019-2033 (USD Million)
13.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Modality (2019-2026)13.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Modality (2027-2033)
14. Global Expanded Hemodialysis Therapy Market, By Application, 2019-2033 (USD Million)
14.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Application (2019-2026)14.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Application (2027-2033)
15. Global Expanded Hemodialysis Therapy Market, By End User, 2019-2033 (USD Million)
15.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By End User (2019-2026)15.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By End User (2027-2033)
16. Global Expanded Hemodialysis Therapy Market, By Region, 2019-2033 (USD Million)
16.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Region (2019-2026)16.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Region (2027-2033)16.3. Asia-Pacific
16.3.1. Australia16.3.2. China16.3.3. India16.3.4. Japan16.3.5. South Korea16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France16.4.2. Germany16.4.3. Italy16.4.4. Spain16.4.5. United Kingdom16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia16.5.2. United Arab Emirates16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada16.6.2. Mexico16.6.3. United States
16.7. Latin America
16.7.1. Argentina16.7.2. Brazil16.7.3. Rest of Latin America
17. Company Profile
17.1. Asahi Kasei Corporation
17.1.1. Company details17.1.2. Financial outlook17.1.3. Product summary17.1.4. Recent developments
17.2. B. Braun Melsungen AG
17.2.1. Company details17.2.2. Financial outlook17.2.3. Product summary17.2.4. Recent developments
17.3. Baxter International Inc.
17.3.1. Company details17.3.2. Financial outlook17.3.3. Product summary17.3.4. Recent developments
17.4. Cantel Medical Corp.
17.4.1. Company details17.4.2. Financial outlook17.4.3. Product summary17.4.4. Recent developments
17.5. Fresenius Medical Care AG & Co. KGaA
17.5.1. Company details17.5.2. Financial outlook17.5.3. Product summary17.5.4. Recent developments
17.6. Nikkiso Co, Ltd.
17.6.1. Company details17.6.2. Financial outlook17.6.3. Product summary17.6.4. Recent developments
17.7. Nipro Corporation
17.7.1. Company details17.7.2. Financial outlook17.7.3. Product summary17.7.4. Recent developments
17.8. NxStage Medical Corp.
17.8.1. Company details17.8.2. Financial outlook17.8.3. Product summary17.8.4. Recent developments
17.9. Satellite Healthcare Inc.
17.9.1. Company details17.9.2. Financial outlook17.9.3. Product summary17.9.4. Recent developments
17.10. MEDIVATORS Inc.
17.10.1. Company details17.10.2. Financial outlook17.10.3. Product summary17.10.4. Recent developments
17.11. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Expanded Hemodialysis Therapy Market is projected to reach USD XX billion by 2033, growing at a CAGR of 5.0% during the forecast period.
Expanded Hemodialysis Therapy Market grew in market size from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of 5.0% during the forecast period.
Expanded Hemodialysis Therapy Market CAGR of 5.0% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Expanded Hemodialysis Therapy Market size is USD XX billion from 2023 to 2033.
Expanded Hemodialysis Therapy Market Segment is covered By Product, By Modality, Application By End User.
The North America is anticipated to have the highest market share in the Expanded Hemodialysis Therapy Market.
The key players in the market include Companies Covered Covered Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc.
A life-sustaining treatment for patients with end-stage kidney disease is hemodialysis. It assists in the blood's removal of waste materials, extra fluid, and electrolytes, all of which help control and lessen kidney failure symptoms.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
